{"id":"https://openalex.org/W46482202","doi":"https://doi.org/10.1096/fasebj.24.1_supplement.597.3","title":"Imidazolines as single agent therapy for diabetics with hypertension","display_name":"Imidazolines as single agent therapy for diabetics with hypertension","alternate_titles":[],"publication_year":2010,"publication_date":"2010-04-01","ids":{"openalex":"https://openalex.org/W46482202","doi":"https://doi.org/10.1096/fasebj.24.1_supplement.597.3","mag":"46482202"},"language":"en","primary_location":{"id":"doi:10.1096/fasebj.24.1_supplement.597.3","doi":"https://doi.org/10.1096/fasebj.24.1_supplement.597.3","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.24.1_supplement.597.3","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W46482202"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020840963","display_name":"Lincoln Paul Edwards","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I26347476","display_name":"Loma Linda University","ror":"https://ror.org/04bj28v14","country_code":"US","type":"education","lineage":["https://openalex.org/I26347476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lincoln Paul Edwards","raw_affiliation_strings":["Center for Dental Research/Physiology/Pharmacology Loma Linda University Loma Linda CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Dental Research/Physiology/Pharmacology Loma Linda University Loma Linda CA","institution_ids":["https://openalex.org/I26347476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111982641","display_name":"Louis J. Crane","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I134560555","display_name":"Universit\u00e9 Toulouse III - Paul Sabatier","ror":"https://ror.org/02v6kpv12","country_code":"FR","type":"education","lineage":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Louis Crane","raw_affiliation_strings":["Faculte des Sciences Pharmaceutiques Universite Paul Sabatier Tolouse France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculte des Sciences Pharmaceutiques Universite Paul Sabatier Tolouse France","institution_ids":["https://openalex.org/I134560555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059200627","display_name":"Genevi\u00e8ve Baziard","orcid":"https://orcid.org/0000-0002-6762-9167","observed_orcids":["https://orcid.org/0000-0002-6762-9167"]},"institutions":[{"id":"https://openalex.org/I134560555","display_name":"Universit\u00e9 Toulouse III - Paul Sabatier","ror":"https://ror.org/02v6kpv12","country_code":"FR","type":"education","lineage":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Genevieve Baziard\u2010Mouysset","raw_affiliation_strings":["Faculte des Sciences Pharmaceutiques Universite Paul Sabatier Tolouse France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculte des Sciences Pharmaceutiques Universite Paul Sabatier Tolouse France","institution_ids":["https://openalex.org/I134560555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028580521","display_name":"Terry A. Brown\u2010Bryan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I52710748","display_name":"Charles R. Drew University of Medicine and Science","ror":"https://ror.org/038x2fh14","country_code":"US","type":"education","lineage":["https://openalex.org/I52710748"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"TerryAnn Brown\u2010Bryan","raw_affiliation_strings":["Charles Drew University of Medicine and Science Los Angeles CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Charles Drew University of Medicine and Science Los Angeles CA","institution_ids":["https://openalex.org/I52710748"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3740,"currency":"USD","value_usd":3740},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"24","issue":"S1","first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9696999788284302,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9696999788284302,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.012000000104308128,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.007699999958276749,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/imidazoline","display_name":"imidazoline","score":0.9269999861717224},{"id":"https://openalex.org/keywords/moxonidine","display_name":"moxonidine","score":0.8960000276565552},{"id":"https://openalex.org/keywords/hypertension-in-diabetes","display_name":"hypertension in diabetes","score":0.7279999852180481},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.7120000123977661},{"id":"https://openalex.org/keywords/blood-pressure-reduction","display_name":"blood pressure reduction","score":0.6019999980926514},{"id":"https://openalex.org/keywords/glucose-uptake","display_name":"glucose uptake","score":0.9739999771118164},{"id":"https://openalex.org/keywords/akt-phosphorylation","display_name":"Akt phosphorylation","score":0.9259999990463257},{"id":"https://openalex.org/keywords/hyperglycemia","display_name":"hyperglycemia","score":0.7789999842643738},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.6079999804496765},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.5529999732971191},{"id":"https://openalex.org/keywords/spontaneously-hypertensive-rats","display_name":"spontaneously hypertensive rats","score":0.9229999780654907}],"concepts":[{"id":"https://openalex.org/C2777014715","wikidata":"https://www.wikidata.org/wiki/Q419944","display_name":"Moxonidine","level":4,"score":0.9954200983047485},{"id":"https://openalex.org/C123605464","wikidata":"https://www.wikidata.org/wiki/Q1659850","display_name":"Imidazoline receptor","level":2,"score":0.7998843193054199},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6184111833572388},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.6131987571716309},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5708112716674805},{"id":"https://openalex.org/C174510640","wikidata":"https://www.wikidata.org/wiki/Q489618","display_name":"HEK 293 cells","level":3,"score":0.4895985722541809},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.4638320207595825},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.4508032202720642},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4495184123516083},{"id":"https://openalex.org/C2781460075","wikidata":"https://www.wikidata.org/wiki/Q1399332","display_name":"Compliance (psychology)","level":2,"score":0.44097253680229187},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.39338546991348267},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3931567966938019},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.35979875922203064},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2257806956768036},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.11741015315055847},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.0},{"id":"https://openalex.org/C77805123","wikidata":"https://www.wikidata.org/wiki/Q161272","display_name":"Social psychology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1096/fasebj.24.1_supplement.597.3","doi":"https://doi.org/10.1096/fasebj.24.1_supplement.597.3","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.24.1_supplement.597.3","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3177312520","https://openalex.org/W1589324970","https://openalex.org/W2778956311","https://openalex.org/W3175410737","https://openalex.org/W187678234","https://openalex.org/W577671087","https://openalex.org/W2092434990","https://openalex.org/W2378201365","https://openalex.org/W4399309484","https://openalex.org/W2404529519"],"abstract_inverted_index":{"Pharmacologic":[0],"treatment":[1,114,160,177],"of":[2,18,76,83,125,159,174],"many":[3],"diabetics":[4,40,194],"also":[5],"involves":[6],"treating":[7],"hypertension.":[8,196],"This":[9],"requires":[10],"taking":[11],"multiple":[12],"drugs,":[13],"which":[14],"increases":[15],"the":[16,30,74,123,167],"risk":[17],"drug":[19],"interaction,":[20],"and":[21,24,58,67,95,135,142],"decrease":[22,59],"compliance":[23],"glycemic":[25],"control.":[26],"Imidazoline":[27],"compounds":[28,51,185],"have":[29],"potential":[31],"to":[32,38,54,121,192],"act":[33,52],"as":[34,189],"single":[35],"agent":[36],"therapy":[37,191],"treat":[39,193],"with":[41,92,115,178,195],"hypertension,":[42],"thereby":[43],"positively":[44],"impacting":[45],"compliance.":[46],"We":[47],"hypothesize":[48],"that":[49,132,183],"imidazoline":[50,100,184],"centrally":[53],"lower":[55],"blood":[56,84],"pressure":[57,139],"hyperglycemia":[60],"by":[61,81,113,140],"stimulating":[62],"glucose":[63,96,154],"uptake.":[64],"Moxonidine":[65,145],"(5nmol)":[66],"S43126":[68,134],"(5nmol),":[69],"were":[70,90],"injected":[71],"cumulatively":[72],"into":[73],"brain":[75],"spontaneously":[77],"hypertensive":[78],"rats,":[79],"followed":[80,112],"measurement":[82],"pressure.":[85],"HEK":[86,109,162],"293":[87,110,163],"kidney":[88],"cells":[89],"treated":[91],"moxonidine":[93,136],"(1\u03bcM)":[94],"uptake":[97,155],"measured.":[98],"The":[99],"receptor":[101],"antisera":[102],"selective":[103],"(IRAS)":[104],"protein":[105,126,169],"was":[106,119],"overexpressed":[107],"in":[108,153,161],"cells,":[111],"moxonidine.":[116,179],"Western":[117],"blot":[118],"used":[120],"determine":[122],"phosphorylation":[124,173],"kinase":[127],"B.":[128],"Our":[129],"results":[130],"showed":[131,170],"both":[133],"lowered":[137],"arterial":[138],"20mmHg":[141],"45mmHg":[143],"respectively.":[144],"caused":[146],"a":[147,171],"greater":[148,172],"than":[149],"6":[150],"fold":[151],"increase":[152],"at":[156],"60":[157],"min":[158],"cells.":[164],"Cells":[165],"overexpressing":[166],"IRAS":[168],"PKB":[175],"after":[176],"These":[180],"data":[181],"suggest":[182],"may":[186],"be":[187],"developed":[188],"alternative":[190]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W46482202","counts_by_year":[{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-18T13:11:19.462570","created_date":"2016-06-24T00:00:00"}
